Results Snapshot
Figures in Million
Consolidate Annual Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
829.45
3.55
240.74
243.23
138.29
87.99
168.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
829.45
3.55
240.74
243.23
138.29
87.99
168.80
Raw Material Cost
23.93
18.59
12.49
10.42
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
204.37
197.97
174.80
189.47
130.53
81.46
36.73
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
89.36
32.35
18.33
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
121.92
96.82
90.93
122.82
80.08
51.66
26.54
Other Expenses
29.15
25.89
14.92
9.90
6.84
4.21
3.99
Total Expenditure (Excl Depreciation)
731.10
604.63
445.74
421.74
279.06
175.21
103.17
Operating Profit (PBDIT) excl Other Income
98.3
-601.1
-205
-178.5
-140.8
-87.2
65.6
Other Income
42.55
20.97
16.84
5.80
8.19
8.61
6.96
Operating Profit (PBDIT)
164.82
-561.51
-175.67
-162.29
-132.58
-78.61
72.59
Interest
89.36
32.35
18.33
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
805.52
-15.04
228.24
232.81
0.00
0.00
0.00
Depreciation
23.93
18.59
12.49
10.42
8.27
5.94
4.44
Profit Before Tax
51.53
-612.46
-206.49
-172.71
-140.85
-84.55
68.15
Tax
21.42
-2.77
2.78
3.79
0.00
0.00
0.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-1.63
-599.49
-205.28
-176.06
-140.85
-84.55
67.97
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-1.63
-599.49
-205.28
-176.06
-140.85
-84.55
67.97
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
31.75
-10.20
-4.00
-0.43
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
30.11
-609.69
-209.28
-176.49
-140.85
-84.55
67.97
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
466.05
185.44
271.34
398.52
408.82
461.78
244.59
Earnings per share (EPS)
-0.01
-5.0
-1.92
-1.67
-1.36
-0.84
0.69
Diluted Earnings per share
-0.01
-5.0
-1.92
-1.67
-1.36
-0.84
0.69
Operating Profit Margin (Excl OI)
11.86%
-16927.06%
-85.16%
-73.39%
-107.77%
-105.87%
36.25%
Gross Profit Margin
9.1%
-16723.88%
-80.59%
-66.72%
-95.87%
-89.34%
43.0%
PAT Margin
-0.2%
-16882.37%
-85.27%
-72.39%
-101.85%
-96.09%
40.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Sep 2025 is 22,938.89% vs -98.50% in Sep 2024
Consolidate Net Profit
YoY Growth in year ended Sep 2025 is 104.94% vs -191.30% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Sep 2025 is 121.00% vs -202.60% in Sep 2024
Interest
YoY Growth in year ended Sep 2025 is 175.93% vs 77.05% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Sep 2025 has improved from Sep 2024
Compare Annual Results Of Arrowhead Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
829.45
12.44
817.01
6,567.60%
Other Operating Income
0.00
0.00
0.00
Total Operating income
829.45
12.44
817.01
6,567.60%
Raw Material Cost
23.93
3.53
20.40
577.90%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
204.37
0.00
204.37
Power Cost
0
0
0.00
Manufacturing Expenses
89.36
0.00
89.36
Selling and Distribution Expenses
121.92
239.80
-117.88
-49.16%
Other Expenses
29.15
52.87
-23.72
-44.86%
Total Expenditure (Excl Depreciation)
731.10
772.03
-40.93
-5.30%
Operating Profit (PBDIT) excl Other Income
98.35
-759.59
857.94
112.95%
Other Income
42.55
19.23
23.32
121.27%
Operating Profit (PBDIT)
164.82
-737.43
902.25
122.35%
Interest
89.36
0.00
89.36
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
805.52
8.91
796.61
8,940.63%
Depreciation
23.93
2.93
21.00
716.72%
Profit Before Tax
51.53
-740.36
791.89
106.96%
Tax
21.42
0.51
20.91
4,100.00%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
-1.63
-740.87
739.24
99.78%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-1.63
-740.87
739.24
99.78%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
31.75
0.00
31.75
Other related items
0.00
0.00
0.00
Consolidated Net Profit
30.11
-740.87
770.98
104.06%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
466.05
996.52
-530.47
-53.23%
Earnings per share (EPS)
-0.01
-13.18
13.17
99.92%
Diluted Earnings per share
-0.01
-13.18
13.17
99.92%
Operating Profit Margin (Excl OI)
11.86%
-6,107.98%
0.00
6,119.84%
Gross Profit Margin
9.10%
-5,929.80%
0.00
5,938.90%
PAT Margin
-0.20%
-5,957.44%
0.00
5,957.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 82.94 Million
in Sep 2025Figures in Million
YoY Growth in year ended Sep 2025 is 22,938.89% vs -98.50% in Sep 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 3.01 Million
in Sep 2025Figures in Million
YoY Growth in year ended Sep 2025 is 104.94% vs -191.30% in Sep 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.23 Million
in Sep 2025Figures in Million
YoY Growth in year ended Sep 2025 is 121.00% vs -202.60% in Sep 2024
Annual - Interest
Interest 8.94 Million
in Sep 2025Figures in Million
YoY Growth in year ended Sep 2025 is 175.93% vs 77.05% in Sep 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.86%
in Sep 2025Figures in %
YoY Growth in year ended Sep 2025 has improved from Sep 2024






